Cargando…

Dyslipidaemia Among Children Living with HIV after 48 Weeks of First-line Antiretroviral Therapy

BACKGROUND: Antiretroviral therapy (ART) associated dyslipidaemia has been reported among children living with HIV (CLHIV) in both developed and developing countries. Not much data is available on changes in blood lipid profile among CLHIV on first-line ART in India. Aims: To study the changes in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Perumal Kannabiran, Bhavani, C, Padmapriyadarsini, N, Sanjeeva G, R, Srinivasan, Shet, Anita, N, Poorana Ganga Devi, Reddy, Devarajulu, Elumalai, Suresh, Wanke, Christine A, Swaminathan, Soumya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631659/
http://dx.doi.org/10.1093/ofid/ofx163.433
_version_ 1783269526386769920
author Perumal Kannabiran, Bhavani
C, Padmapriyadarsini
N, Sanjeeva G
R, Srinivasan
Shet, Anita
N, Poorana Ganga Devi
Reddy, Devarajulu
Elumalai, Suresh
Wanke, Christine A
Swaminathan, Soumya
author_facet Perumal Kannabiran, Bhavani
C, Padmapriyadarsini
N, Sanjeeva G
R, Srinivasan
Shet, Anita
N, Poorana Ganga Devi
Reddy, Devarajulu
Elumalai, Suresh
Wanke, Christine A
Swaminathan, Soumya
author_sort Perumal Kannabiran, Bhavani
collection PubMed
description BACKGROUND: Antiretroviral therapy (ART) associated dyslipidaemia has been reported among children living with HIV (CLHIV) in both developed and developing countries. Not much data is available on changes in blood lipid profile among CLHIV on first-line ART in India. Aims: To study the changes in the Lipid profile among CLHIVs, 12 months after initiating a non-nucleoside reverse transcriptase inhibitor-based (NNRTI) ART METHODS: A prospective multicentric study enrolled HIV infected children, between 2-12 years of age, initiating NNRTI-based ART in south India. Clinical details, anthropometry and fasting blood for estimating serum total cholesterol (TC), triglyceride (TGL), high-density cholesterol (HDL-c), low-density cholesterol (LDL-c), plasma viral load and CD4 cell counts was collected. These measurements were repeated at 6(th) and 12(th) month after ART initiation. Proportion of children with abnormal lipid profile at baseline and 12 months after ART were compared using McNemar test. Generalized linear model was applied to predict factors associated with changes in serum lipid levels 12 months post-ART. RESULTS: Of the 393 HIV-infected children, 66 % received Zidovudine and 14 % Stavudine in their ART regimen. After 12 months of ART, TC, LDL-c and HDL-c increased from baseline by a mean of 31mg/dL, 13.7 mg/dL and 19mg/dl, respectively. TC/HDL-c ratio decreased from a mean of 5.1 to 3.5 (all changes, P <0.000). At baseline and 12 months, respectively, TC was >200 mg/dL for 3% and 13% of patients, LDL-c was >130 mg/dL for 5% and 8%, HDL-c was <35 mg/dL for 70% and 16%, and TG were >150 mg/dL for 38% and 24%. Baseline HIV viral load >400 copies/mL (P, 0.01) was associated with increase in HDL-c and lower TG levels (P, 0.008). Baseline CD4 % <15 and younger age group were significantly associated with increase in TC (P, 0.02) and decrease in TGL (P,0.02) after 12-months of ART. CONCLUSION: Significant changes in serum lipid profile occurs early in children started on first-line ART. Increase in the cardio protective HDL-c was proportionally greater than increases in TC or TGL. Regular monitoring of lipid levels will help in early identification of metabolic complications of ART DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5631659
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56316592017-11-07 Dyslipidaemia Among Children Living with HIV after 48 Weeks of First-line Antiretroviral Therapy Perumal Kannabiran, Bhavani C, Padmapriyadarsini N, Sanjeeva G R, Srinivasan Shet, Anita N, Poorana Ganga Devi Reddy, Devarajulu Elumalai, Suresh Wanke, Christine A Swaminathan, Soumya Open Forum Infect Dis Abstracts BACKGROUND: Antiretroviral therapy (ART) associated dyslipidaemia has been reported among children living with HIV (CLHIV) in both developed and developing countries. Not much data is available on changes in blood lipid profile among CLHIV on first-line ART in India. Aims: To study the changes in the Lipid profile among CLHIVs, 12 months after initiating a non-nucleoside reverse transcriptase inhibitor-based (NNRTI) ART METHODS: A prospective multicentric study enrolled HIV infected children, between 2-12 years of age, initiating NNRTI-based ART in south India. Clinical details, anthropometry and fasting blood for estimating serum total cholesterol (TC), triglyceride (TGL), high-density cholesterol (HDL-c), low-density cholesterol (LDL-c), plasma viral load and CD4 cell counts was collected. These measurements were repeated at 6(th) and 12(th) month after ART initiation. Proportion of children with abnormal lipid profile at baseline and 12 months after ART were compared using McNemar test. Generalized linear model was applied to predict factors associated with changes in serum lipid levels 12 months post-ART. RESULTS: Of the 393 HIV-infected children, 66 % received Zidovudine and 14 % Stavudine in their ART regimen. After 12 months of ART, TC, LDL-c and HDL-c increased from baseline by a mean of 31mg/dL, 13.7 mg/dL and 19mg/dl, respectively. TC/HDL-c ratio decreased from a mean of 5.1 to 3.5 (all changes, P <0.000). At baseline and 12 months, respectively, TC was >200 mg/dL for 3% and 13% of patients, LDL-c was >130 mg/dL for 5% and 8%, HDL-c was <35 mg/dL for 70% and 16%, and TG were >150 mg/dL for 38% and 24%. Baseline HIV viral load >400 copies/mL (P, 0.01) was associated with increase in HDL-c and lower TG levels (P, 0.008). Baseline CD4 % <15 and younger age group were significantly associated with increase in TC (P, 0.02) and decrease in TGL (P,0.02) after 12-months of ART. CONCLUSION: Significant changes in serum lipid profile occurs early in children started on first-line ART. Increase in the cardio protective HDL-c was proportionally greater than increases in TC or TGL. Regular monitoring of lipid levels will help in early identification of metabolic complications of ART DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631659/ http://dx.doi.org/10.1093/ofid/ofx163.433 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Perumal Kannabiran, Bhavani
C, Padmapriyadarsini
N, Sanjeeva G
R, Srinivasan
Shet, Anita
N, Poorana Ganga Devi
Reddy, Devarajulu
Elumalai, Suresh
Wanke, Christine A
Swaminathan, Soumya
Dyslipidaemia Among Children Living with HIV after 48 Weeks of First-line Antiretroviral Therapy
title Dyslipidaemia Among Children Living with HIV after 48 Weeks of First-line Antiretroviral Therapy
title_full Dyslipidaemia Among Children Living with HIV after 48 Weeks of First-line Antiretroviral Therapy
title_fullStr Dyslipidaemia Among Children Living with HIV after 48 Weeks of First-line Antiretroviral Therapy
title_full_unstemmed Dyslipidaemia Among Children Living with HIV after 48 Weeks of First-line Antiretroviral Therapy
title_short Dyslipidaemia Among Children Living with HIV after 48 Weeks of First-line Antiretroviral Therapy
title_sort dyslipidaemia among children living with hiv after 48 weeks of first-line antiretroviral therapy
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631659/
http://dx.doi.org/10.1093/ofid/ofx163.433
work_keys_str_mv AT perumalkannabiranbhavani dyslipidaemiaamongchildrenlivingwithhivafter48weeksoffirstlineantiretroviraltherapy
AT cpadmapriyadarsini dyslipidaemiaamongchildrenlivingwithhivafter48weeksoffirstlineantiretroviraltherapy
AT nsanjeevag dyslipidaemiaamongchildrenlivingwithhivafter48weeksoffirstlineantiretroviraltherapy
AT rsrinivasan dyslipidaemiaamongchildrenlivingwithhivafter48weeksoffirstlineantiretroviraltherapy
AT shetanita dyslipidaemiaamongchildrenlivingwithhivafter48weeksoffirstlineantiretroviraltherapy
AT npooranagangadevi dyslipidaemiaamongchildrenlivingwithhivafter48weeksoffirstlineantiretroviraltherapy
AT reddydevarajulu dyslipidaemiaamongchildrenlivingwithhivafter48weeksoffirstlineantiretroviraltherapy
AT elumalaisuresh dyslipidaemiaamongchildrenlivingwithhivafter48weeksoffirstlineantiretroviraltherapy
AT wankechristinea dyslipidaemiaamongchildrenlivingwithhivafter48weeksoffirstlineantiretroviraltherapy
AT swaminathansoumya dyslipidaemiaamongchildrenlivingwithhivafter48weeksoffirstlineantiretroviraltherapy